3
Announcements
Trials
Browse
Landscape
Phase
Phase 1
1
Status
Withdrawn
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Head & Neck
1
Endocrine
1
Conditions
Thyroid Carcinoma, Anaplastic
1
Interventions
Cisplatin
21
pembrolizumab
12
Cetuximab
12
Radiotherapy
11
Carboplatin
10
Nivolumab
9
Radiotherapy, Intensity-Modulated
8
Fluorouracil
8
durvalumab
5
Standard of Care
5
epacadostat
4
Paclitaxel
4
Magnetic Resonance Spectroscopy
4
Drug Therapy
4
Cyclophosphamide
4
X-Rays
3
Radiosurgery
3
Radiation
3
Practice Guidelines as Topic
3
Panitumumab
3
Gene Expression Profiling
3
Docetaxel
3
Biopsy
3
fluoromisonidazole
2
fludarabine
2
cemiplimab
2
aldesleukin
2
Venlafaxine Hydrochloride
2
Thyroxine
2
Surveys and Questionnaires
2
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Withdrawn
×
Adalimumab
×
Head & Neck
×
Clear all
NCT02516774
2016-01-26
TAM-RT
Gustave Roussy, Cancer Campus, Grand Paris
Phase 1
Withdrawn